Halting the Tuberculosis Epidemic with Research and Diagnostics: A Conversation with David Alland

<p>Welcome to The Scientist’s LabTalk, a special edition podcast produced by The Scientist’s Creative Services Team where we explore topics at the leading edge of innovative research. This episode is brought to you by Keystone Symposia. Don’t miss their upcoming virtual eSymposia <a href='https://keysym.us/EK10ScientistPod'>Tuberculosis: Science Aimed at Ending the Epidemic</a> on December 2-4, 2020.</p> <p>One of the symposium’s co-organizers and keynote speaker is David Alland, Chief of Infectious Disease and Director of the Center for Emerging Pathogens and the Center for COVID-19 Response and Pandemic Preparedness at Rutgers New Jersey Medical School. Niki Spahich from The Scientist’s Creative Services team spoke with Alland about his journey to develop a rapid, point-of-care tuberculosis diagnostic and his current research on mutations that lead to drug resistance.</p>